Christine Ahlstrom
BioPharmaceuticals R&D
Goeteborg, O, Sweden
Goeteborg, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Plasma proteomics stratification identifies phospholamban R14del carriers at risk for disease progression.
Journal: Cardiovascular research
Published: January 14, 2026
Phosphoproteomics distinguishes disease-specific mechanisms for human phospholamban cardiomyopathy reversible by RNA therapy.
Journal: Signal transduction and targeted therapy
Published: December 15, 2025
Integrated Physiologically-Based Pharmacokinetic Model with a Quantitative Systems Pharmacology and Toxicology Model for Statins in Disease Population. Part 1: Model Development and Validation.
Journal: The AAPS journal
Published: July 11, 2025
Integrated Physiologically-based Pharmacokinetic Model with a Quantitative Systems Pharmacology and Toxicology Model for Statins in Disease Population. Part 2: MIDD and MIPD Applications.
Journal: The AAPS journal
Published: July 11, 2025
Translational PK/PD: a retrospective analysis of performance and impact from a drug portfolio.
Journal: Drug discovery today
Published: January 22, 2025
SGLT2 inhibition improves coronary flow velocity reserve and contractility: role of glucagon signaling.
Journal: Cardiovascular diabetology
Published: July 30, 2024
Physiologically based pharmacokinetics modeling and transporter proteomics to predict systemic and local liver and muscle disposition of statins.
Journal: CPT: pharmacometrics & systems pharmacology
Published: November 22, 2023
The role of venous capacity in fluid retention with endothelin A antagonism: Mathematical modelling of the RADAR trial.
Journal: British journal of pharmacology
Published: November 03, 2023
Efficacy and safety of zibotentan and dapagliflozin in patients with chronic kidney disease: study design and baseline characteristics of the ZENITH-CKD trial.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: July 07, 2023
Understanding Statin-Roxadustat Drug-Drug-Disease Interaction Using Physiologically-Based Pharmacokinetic Modeling.
Journal: Clinical pharmacology and therapeutics
Published: February 27, 2023
The sodium glucose co-transporter 2 inhibitor dapagliflozin ameliorates the fluid-retaining effect of the endothelin A receptor antagonist zibotentan.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: January 13, 2023
Does the choice of applied physiologically-based pharmacokinetics platform matter? A case study on simvastatin disposition and drug-drug interaction.
Journal: CPT: pharmacometrics & systems pharmacology
Published: March 15, 2022
Last Updated: 09/26/2026